share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hickey Benjamin

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
SEC announcement ·  03/12 17:49
Moomoo AI 已提取核心信息
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
2024年3月10日，RayzeBio Org. 总裁本杰明·希基进行了一项涉及百时美施贵宝（BMY）普通股的交易。交易完成后，Hickey直接持有该公司780股普通股，每股面值为0.10美元。此外，Hickey的配偶间接持有91股股份，使实际所有权总数达到871股。间接所有权的性质被规定为通过配偶拥有。该交易反映了公司内部关键个人的持股变化，当前和潜在投资者可能会对此感兴趣。
2024年3月10日，RayzeBio Org. 总裁本杰明·希基进行了一项涉及百时美施贵宝（BMY）普通股的交易。交易完成后，Hickey直接持有该公司780股普通股，每股面值为0.10美元。此外，Hickey的配偶间接持有91股股份，使实际所有权总数达到871股。间接所有权的性质被规定为通过配偶拥有。该交易反映了公司内部关键个人的持股变化，当前和潜在投资者可能会对此感兴趣。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息